Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0VA2I
|
|||
| Former ID |
DCL000095
|
|||
| Drug Name |
CRx-191
|
|||
| Indication | Psoriatic disorder [ICD-11: EA90; ICD-9: 696] | Discontinued in Phase 2 | [1] | |
| Company |
CombinatoRx
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025635) | |||
| REF 2 | CombinatoRx Drug Candidate CRx-191 Demonstrates Positive Phase 2 Results In Psoriasis. CombinatoRx. 2008. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.